Lily Yip
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- Modeling and Simulation top 5%
Papers in
-
- Biochemical and Molecular Research 18
- Porphyrin Metabolism and Disorders 3
-
- HIV/AIDS drug development and treatment 11
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
- Co-authors
- M. Earl Balis (18 shared papers)Samira Mubareka (16 shared papers)Joseph Dancis (5 shared papers)Allison McGeer (10 shared papers)David N. Douda (1 shared paper)Hartmut Grasemann (1 shared paper)Meraj A. Khan (1 shared paper)Nades Palaniyar (1 shared paper)
- Journals
- Biochemistry (5 papers)Biochemical Pharmacology (2 papers)Influenza and Other Respiratory Viruses (2 papers)Journal of Surgical Oncology (2 papers)Advances in experimental medicine and biology (2 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Lily Yip
43 papers receiving 924 citations
Peers
Comparison fields: 5 of 117
- Infectious Diseases 390
- Modeling and Simulation 42
- Epidemiology 228
- Molecular Biology 465
- Immunology 129
Countries citing papers authored by Lily Yip
This map shows the geographic impact of Lily Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Yip more than expected).
Fields of papers citing papers by Lily Yip
This network shows the impact of papers produced by Lily Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Yip. The network helps show where Lily Yip may publish in the future.
Co-authors
The 25 scholars most cited alongside Lily Yip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 188 | |
| 2 | 2014 | 125 | |
| 3 | 1971 | 84 | |
| 4 | 2020 | 72 | |
| 5 | 2021 | 44 | |
| 6 | 1977 | 43 | |
| 7 | 1984 | 42 | |
| 8 | 1973 | 38 | |
| 9 | 2020 | 35 | |
| 10 | 2020 | 33 | |
| 11 | 2021 | 32 | |
| 12 | 2021 | 25 | |
| 13 | 2019 | 22 | |
| 14 | 1978 | 21 | |
| 15 | 1973 | 19 | |
| 16 | 1974 | 18 | |
| 17 | 1980 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 1974 | 14 | |
| 20 | 1974 | 10 |
About Lily Yip
Lily Yip is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine and Physiology, having authored 48 papers that have together received 999 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (18 papers), HIV/AIDS drug development and treatment (11 papers), Cytomegalovirus and herpesvirus research (9 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Infection Control and Ventilation (4 papers), Adenosine and Purinergic Signaling (4 papers), COVID-19 Clinical Research Studies (4 papers) and Porphyrin Metabolism and Disorders (3 papers). The work is most often cited by research in Infectious Diseases (390 citations), Modeling and Simulation (42 citations), Epidemiology (228 citations), Molecular Biology (465 citations) and Immunology (129 citations). Lily Yip has collaborated with scholars based in Canada, United States and China. Frequent co-authors include M. Earl Balis, Samira Mubareka, Joseph Dancis, Allison McGeer, David N. Douda, Hartmut Grasemann, Meraj A. Khan, Nades Palaniyar, Charles S. Rubin and Robert C. Nowinski. Their work appears in journals such as Biochemistry, Biochemical Pharmacology, Influenza and Other Respiratory Viruses, Journal of Surgical Oncology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.